| 218.22 Delayed Data As of Nov 13 |  -1.64 / -0.74%Today’s Change | 166.30 Today|||52-Week Range 225.26 | +12.10% Year-to-Date |
| Amarin's Stock Could Reach $50 Per Share Soon Nov 13 / MotleyFool.com - Paid Partner Content | Here's Why Cytokinetics Stock Tanked on Thursday Nov 07 / MotleyFool.com - Paid Partner Content |
| Here’s Why FibroGen’s Stock Popped Friday Nov 11 / MotleyFool.com - Paid Partner Content | Buy These 2 Stocks to Access China's Huge Healthcare Market Nov 06 / MotleyFool.com - Paid Partner Content |
| Why Amgen's Stock Soared in October Nov 11 / MotleyFool.com - Paid Partner Content | Better Buy: Mirati Therapeutics vs. Amgen Nov 02 / MotleyFool.com - Paid Partner Content |
| 3 Cancer Treatment Stocks to Buy Right Now Nov 09 / MotleyFool.com - Paid Partner Content | Here's Why Beigene Stock Is Soaring Today Nov 01 / MotleyFool.com - Paid Partner Content |
| Previous close | 221.31 |
| Today’s open | 220.43 |
| Day’s range | 218.54 - 221.69 |
| Volume | 2,349,050 |
| Average volume (3 months) | 2,823,896 |
| Market cap | $131.0B |
| Earnings growth (last year) | +368.59% |
| Earnings growth (this year) | +0.16% |
| Earnings growth (next 5 years) | +8.00% |
| Revenue growth (last year) | +4.32% |
| P/E ratio | 16.9 |
| Price/Sales | 5.45 |
| Price/Book | 11.10 |
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | -0.99 | -1.54% |
| BIIBBiogen | -9.51 | -3.26% |
| ILMNIllumina Inc | +2.49 | +0.84% |
| BMRNBiomarin Pharmaceuti... | +0.26 | +0.34% |
| Next reporting date | January 30, 2020 |
| EPS forecast (this quarter) | $3.25 |
| Annual revenue (last year) | $23.8B |
| Annual profit (last year) | $8.4B |
| Net profit margin | 35.32% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Thousand Oaks, California |
